JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elhendy, A.
Right arrow Articles by Poldermans, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhendy, A.
Right arrow Articles by Poldermans, D.
Journal of Nuclear Medicine Vol. 46 No. 12 2003-2008
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Risk Stratification of Patients with Angina Pectoris by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging

Abdou Elhendy, MD, PhD1,2, Arend F.L. Schinkel, MD, PhD1, Ron T. van Domburg, PhD1, Jeroen J. Bax, MD, PhD3, Roelf Valkema, MD, PhD4, Aukje Huurman, MSc1, Harm H. Feringa, MD1 and Don Poldermans, MD, PhD1

1 Thoraxcenter, University Hospital Rotterdam, Rotterdam, The Netherlands
2 University of Nebraska Medical Center, Omaha, Nebraska
3 Leiden University Hospital, Leiden, The Netherlands
4 Department of Nuclear Medicine, University Hospital Rotterdam, Rotterdam, The Netherlands

Angina pectoris is a major symptom associated with myocardial ischemia. The aim of this study was to find whether stress myocardial perfusion imaging can independently predict mortality in patients with angina. Methods: We studied 455 patients with stable angina pectoris by exercise or dobutamine stress 99mTc-tetrofosmin myocardial perfusion tomographic imaging. An abnormal finding was defined as a reversible or fixed perfusion abnormality. The endpoint during follow-up was death from any cause. Results: Mean age was 60 ± 10 y. There were 266 men (58% of the patients). Myocardial perfusion was normal in 137 patients (30%). Perfusion abnormalities were reversible in 167 patients and fixed in 151 patients. During a mean follow-up of 6 ± 1.7 y, 93 patients (20%) died. The annual mortality rate was 1.5% in patients with normal perfusion and 4.5% in patients with abnormal perfusion. Patients with a multivessel distribution of perfusion abnormalities had a higher annual death rate than patients with abnormalities in a single-vessel distribution (5.1% vs. 3.7%). In a multivariate analysis model, independent predictors of death were age (risk ratio, 1.05; 95% confidence interval [CI], 1.03–1.08), the male sex (risk ratio, 2.1; CI, 1.3–3.4), diabetes (risk ratio, 2.2; CI, 1.4–3.5), heart failure (risk ratio, 2.7; CI, 1.6–4.5), smoking (risk ratio, 1.7; CI, 1.1–2.6), reversible perfusion abnormalities (risk ratio, 1.9; CI, 1.1–2.8), and fixed perfusion abnormalities (risk ratio, 2; CI, 1.2–3.1). Conclusion: Stress 99mTc-tetrofosmin myocardial perfusion imaging provides independent information for predicting mortality in patients with stable angina pectoris. Both reversible and fixed defects are associated with an increased risk of death. The extent of stress perfusion abnormalities is a major determinant of mortality. Patients with normal perfusion have a low mortality rate during long-term follow-up.

Key Words: angina pectoris • radionuclide imaging • coronary artery disease • prognosis


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. D. Metz, M. Beattie, R. Hom, R. F. Redberg, D. Grady, and K. E. Fleischmann
The Prognostic Value of Normal Exercise Myocardial Perfusion Imaging and Exercise Echocardiography: A Meta-Analysis
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 227 - 237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.